文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

雌激素及雌激素受体在甲状腺癌发生发展中的信号通路

Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer.

作者信息

Liu Jian, Xu Tianmin, Ma Li, Chang Weiqin

机构信息

Department of Gynaecology and Obstetrics, Jilin University Second Hospital, Changchun, China.

Department of Thyroid Surgery, Jilin University Second Hospital, Changchun, China.

出版信息

Front Oncol. 2021 Apr 28;11:593479. doi: 10.3389/fonc.2021.593479. eCollection 2021.


DOI:10.3389/fonc.2021.593479
PMID:33996538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113849/
Abstract

The molecular mechanisms underlying the development of thyroid cancer (TC) have been examined through extensive experiments. A large number of studies have shown that the incidences of thyroid cancer in women is much higher than that in men, so estrogen plays a key role in the development of thyroid cancer. Estrogen plays its growth-promoting role through classical genomic and non-genomic pathways mediated by membrane-bound estrogen receptors. It also can affect tumor progression by regulating the tumor microenvironment. We summarize the understanding of molecular mechanisms of estrogen signaling pathways in thyroid cancer. Furthermore, it will provide a new target for the treatment of thyroid carcinoma by blocking estrogen and its related action pathway.

摘要

通过广泛的实验研究了甲状腺癌(TC)发生发展的分子机制。大量研究表明,女性甲状腺癌的发病率远高于男性,因此雌激素在甲状腺癌的发生发展中起关键作用。雌激素通过由膜结合雌激素受体介导的经典基因组和非基因组途径发挥其促生长作用。它还可通过调节肿瘤微环境影响肿瘤进展。我们总结了对甲状腺癌中雌激素信号通路分子机制的认识。此外,通过阻断雌激素及其相关作用途径,将为甲状腺癌的治疗提供新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229e/8113849/695f3289a018/fonc-11-593479-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229e/8113849/695f3289a018/fonc-11-593479-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229e/8113849/695f3289a018/fonc-11-593479-g0001.jpg

相似文献

[1]
Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer.

Front Oncol. 2021-4-28

[2]
Estrogen and its role in thyroid cancer.

Endocr Relat Cancer. 2014-10

[3]
Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.

Int J Oncol. 2010-5

[4]
Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.

Surgery. 2018-1

[5]
Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms.

J Clin Endocrinol Metab. 2001-3

[6]
Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway.

Front Oncol. 2022-1-12

[7]
Estrogen receptors and glucocorticoid receptors in human well-differentiated thyroid cancer.

Int J Mol Med. 1998-8

[8]
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

Mol Pharmacol. 2006-10

[9]
Modulatory role of 17β-estradiol in the tumor microenvironment of thyroid cancer.

IUBMB Life. 2016-2

[10]
Gender differences in thyroid cancer: a critical review.

Expert Rev Endocrinol Metab. 2011-3

引用本文的文献

[1]
Advances in PD-1/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives.

Front Immunol. 2025-8-8

[2]
Global, regional, and national burden of Pediatric and adolescent thyroid cancer from 1990 to 2021: a statistical analysis of prevalence, incidence, and DALYs.

Front Oncol. 2025-7-29

[3]
Temporal trends and geographic disparities in thyroid cancer burden: a global analysis from 1990 to 2021.

Front Nutr. 2025-7-16

[4]
Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data.

Sci Rep. 2025-7-2

[5]
Assessing the influence of metabolic syndrome on thyroid cancer: insights from a Mendelian randomization approach.

Discov Oncol. 2025-6-10

[6]
Analysis and prediction of contralateral central lymph node metastasis risk in unilateral papillary thyroid carcinoma with ipsilateral lateral cervical lymph node: a retrospective clinical study.

Gland Surg. 2025-3-31

[7]
Systems biology approach delineates critical pathways associated with papillary thyroid cancer: a multi-omics data analysis.

Thyroid Res. 2025-4-11

[8]
Mimicking women's endocrine milieu in mice for women's health-related studies.

NPJ Womens Health. 2025

[9]
Global burden of thyroid cancer in adolescents and young adults (aged 15-39 years) from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021.

PLoS One. 2025-2-14

[10]
Decoding the mechanisms behind second primary cancers.

J Transl Med. 2025-1-24

本文引用的文献

[1]
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.

Int J Mol Sci. 2021-2-6

[2]
Thyroid Carcinoma: Do We Need to Treat Men and Women Differently?

Visc Med. 2020-2

[3]
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.

Int J Mol Sci. 2019-9-7

[4]
Long non-coding RNA H19 may be a marker for prediction of prognosis in the follow-up of patients with papillary thyroid cancer.

Cancer Biomark. 2019

[5]
The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis.

Oxid Med Cell Longev. 2019-1-9

[6]
PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.

Sci Rep. 2019-1-31

[7]
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.

J Med Chem. 2019-2-4

[8]
Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16.

Bull Exp Biol Med. 2018-12

[9]
Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.

Cell Death Dis. 2018-11-2

[10]
Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axis.

Drug Dev Res. 2018-9-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索